Literature DB >> 4402503

Use of alprenolol in acute cardiac arrhythmias.

L Lemberg, A G Arcebal, A Castellanos, D Slavin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4402503     DOI: 10.1016/0002-9149(72)90129-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

Review 3.  Beta-adrenoceptor blocking drugs and acute myocardial infarction.

Authors:  B N Singh
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

4.  Steady-state plasma concentrations of alprenolol in man.

Authors:  M D Rawlins; P Collste; M Frisk-Holmberg; M Lind; J Ostman; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 5.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors:  B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

Authors:  P R Rossi; S Yusuf; D Ramsdale; L Furze; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.